Thromb Haemost 1988; 60(01): 113-120
DOI: 10.1055/s-0038-1647646
Original Article
Schattauer GmbH Stuttgart

Fibrinogen Nijmegen : Congenital Dysfibrinogenemia Associated with Impaired t-PA Mediated Plasminogen Activation and Decreased Binding of t-PA

Luzia Engesser
1   The Gaubius Institute TNO, Leiden, The Netherlands
2   The Department of Hematology, University Hospital Leiden, Leiden, The Netherlands
,
Jaap Koopman
1   The Gaubius Institute TNO, Leiden, The Netherlands
,
Gé de Munk
1   The Gaubius Institute TNO, Leiden, The Netherlands
,
Frits Haverkate
1   The Gaubius Institute TNO, Leiden, The Netherlands
,
Irena Novéková
3   The Sint Radboud Ziekenhuis, Nijmegen, The Netherlands
,
Jan H Verheijen
1   The Gaubius Institute TNO, Leiden, The Netherlands
,
Ernest Briët
2   The Department of Hematology, University Hospital Leiden, Leiden, The Netherlands
,
Emile J P Brommer
1   The Gaubius Institute TNO, Leiden, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 17. März 1988

Accepted after revision 06. Mai 1988

Publikationsdatum:
24. Juli 2018 (online)

Zoom Image

Summary

Congenital dysfibrinogenemia was found in a patient with venous thrombosis. Blood clot lysis was prolonged and suggested an impairment of fibrinolysis. We investigated whether this was related to the fibrinogen abormality. Fibrinopeptide release was normal but fibrin polymerization was defective in the patient. The stimulating effect of the patient’s fibrin on t-PA mediated plasminogen activation was impaired. This could not be attributed to defective binding of plasminogen. However, the binding of t-PA to the patient’s fibrin was about 16% less than to normal fibrin. A variant t-PA (G K1 K2 P), which contained only one of the two fibrin binding sites, i.e. the kringle-2 domain, was bound to the abnormal fibrin for only 50% of normal.

We conclude that the prolongation of blood clot lysis and the impaired stimulation of t-PA mediated plasminogen activation are related to the defective binding of the kringle-2 domain of t-PA onto the fibrin moiety of the abnormal fibrinogen. The impairment of fibrinolysis might explain the occurrence of throm-bosis in the patient.